Renata Talar-Wojnarowska

Medical University

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (13)

Dorota Wasko-Czopnik

prof. uczelni

Wrocław University of Scince and Technology

POLAND

View details

Piotr Eder

Assoc. Prof.

Poznan University of Medical Sciences

POLAND

View details

Marcin Sochal

Medical University of Lodz

POLAND

View details

Jakub Fichna

Medical University of Lodz

POLAND

View details

Agata Gabryelska

Medical University of Lodz

POLAND

View details

Anna Pietrzak

Head of the department

Centre of Postgraduate Medical Education

POLAND

View details

Ewa Malecka-Wojciesko

Medical University of Lodz

POLAND

View details

Giovanni Capretti

Humanitas University

ITALY

View details

Gennaro Nappo

Humanitas University

ITALY

View details

Kasper Sipowicz

The Maria Grzegorzewska University

POLAND

View details

Marek Hartleb

Professor, Head of Department

Medical University of Silesia

POLAND

View details

Edyta Zagorowicz

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Silvia Carrara

Humanitas University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Renata Talar-Wojnarowska

Research Interests

Explore related searches

Contact this professor

Articles (20)

Clinical nutrition in gastrointestinal diseases: an up-to-date clinical practice guideline.

Efficacy of Upadacitinib Induction Treatment in Moderate-to-Severe Ulcerative Colitis Including Intestinal Ultrasound Assessment: A Multicenter, Real-World Observational Study

A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma

Advancements in dual biologic therapy for inflammatory bowel diseases: efficacy, safety, and future directions

Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk

Safety and Effectiveness of Thiopurines and Small Molecules in Elderly Patients with Inflammatory Bowel Diseases

Comparison of ustekinumab, infliximab and combination therapy in moderately to severely active ulcerative colitis - a study protocol of a randomized, multicenter, head-to-head COMBO-UC trial

Current Approach to Risk Factors and Biomarkers of Intestinal Fibrosis in Inflammatory Bowel Disease

Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn’s disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II)

Inflammatory Bowel Diseases in the Elderly: A Focus on Disease Characteristics and Biological Therapy Patterns

CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation

Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational study

Clinical and Laboratory Characteristics of Anaemia in Hospitalized Patients with Inflammatory Bowel Disease

Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease

Neurological Manifestations and Psychiatric Disorders in the Course of Inflammatory Bowel Diseases

The effect of curcumin on symptoms and quality of life in patients with irritable bowel syndrome

The Association between Temperament, Chronotype, Depressive Symptoms, and Disease Activity among Patients with Inflammatory Bowel Disease—A Cross-Sectional Pilot Study

Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment

Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy

Brain‐derived neurotrophic factor is elevated in the blood serum of Crohn's disease patients, but is not influenced by anti‐TNF‐α treatment—A pilot study

Collaborators (13)

Dorota Wasko-Czopnik

Piotr Eder

Marcin Sochal

Jakub Fichna

Agata Gabryelska

Anna Pietrzak

Ewa Malecka-Wojciesko

Giovanni Capretti

Gennaro Nappo

Kasper Sipowicz

Marek Hartleb

Edyta Zagorowicz

Silvia Carrara

Make your next move.